首页> 美国卫生研究院文献>other >Fabrication of mAb G250-SPIO Molecular Magnetic Resonance Imaging Nanoprobe for the Specific Detection of Renal Cell Carcinoma In Vitro
【2h】

Fabrication of mAb G250-SPIO Molecular Magnetic Resonance Imaging Nanoprobe for the Specific Detection of Renal Cell Carcinoma In Vitro

机译:mAb G250-SPIO分子磁共振成像纳米探针的制备用于体外肾细胞癌的特异性检测

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Molecular magnetic resonance imaging (mMRI) has been paid more and more attention for early diagnosis of cancer. A sensitive and specific mMRI probe plays the most important role in this technique. In this study, superparamagnetic iron oxide (SPIO) nanoparticles and mAb G250 were conjugated as mMRI probe for the detection of clear cell renal cell carcinoma (ccRCC) using 3.0-Tesla MRI in vitro. mAb G250 could specifically recognize carbonic anhydrase IX (CAIX) antigen overexpressed in ccRCC and the SPIO nanoparticles as MRI contrast agent presented excellent MRI response and good biocompatibility. The successful assembly of this nanoprobe was confirmed by UV-vis spectrum, FT-IR spectroscopy and DLS analysis. In vitro MRI study on ccRCC cells and control cells indicated that our fabricated mAb G250-SPIO nanoprobe could be used in the specific labeling of clear cell renal carcinoma cells successfully.
机译:分子磁共振成像(mMRI)已被越来越多地用于癌症的早期诊断。灵敏且特异的mMRI探针在该技术中起着最重要的作用。在这项研究中,将超顺磁性氧化铁(SPIO)纳米颗粒和mAb G250结合作为mMRI探针,使用3.0-Tesla MRI体外检测透明细胞肾细胞癌(ccRCC)。 mAb G250可以特异性识别ccRCC和SPIO纳米颗粒中过表达的碳酸酐酶IX(CAIX)抗原,因为MRI造影剂具有出色的MRI反应和良好的生物相容性。紫外可见光谱,FT-IR光谱和DLS分析证实了该纳米探针的成功组装。对ccRCC细胞和对照细胞的体外MRI研究表明,我们制备的mAb G250-SPIO纳米探针可成功用于透明细胞肾癌细胞的特异性标记。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号